2012-09-18 08:08:14 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Influenza - Pipeline Review, H2 2012', provides an overview of the Influenza therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Influenza. 'Influenza - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at

- www.fastmr.com/prod/463824_influenza_pipeline_review_h2_2012.asp ..


Scope

* A snapshot of the global therapeutic scenario for Influenza.
* A review of the Influenza products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Influenza pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Influenza.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Influenza pipeline depth and focus of Influenza therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Influenza Therapeutic Products under Development, Key Players in Influenza Therapeutics, Influenza Pipeline Overview, Influenza Pipeline, Influenza Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Influenza Overview
Therapeutics Development
An Overview of Pipeline Products for Influenza
Influenza Therapeutics under Development by Companies
Influenza Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Influenza Therapeutics - Products under Development by Companies
Influenza Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Influenza Therapeutics Development
Baxter International Inc.
Johnson & Johnson
Vical Incorporated
Sanofi-Aventis
AstraZeneca PLC
GlaxoSmithKline plc
Inovio Biomedical Corporation
MedImmune LLC
Daiichi Sankyo Company, Ltd
Emergent BioSolutions Inc.
Lentigen Corporation
Generex Biotechnology Corporation
Ceragenix Pharmaceuticals, Inc.
Celltrion, Inc.
Nanotherapeutics, Inc.
Liquidia Technologies, Inc.
Ambrilia Biopharma Inc.
Novartis AG
Aphios Corporation
MDRNA, Inc.
Novavax, Inc.
Toyama Chemical Co. Ltd
Vertex Pharmaceuticals Incorporated
CEL-SCI Corporation
AVI BioPharma Inc.
Crucell N.V.
OPKO Health, Inc.
Zosano Pharma, Inc.
4SC AG
Hemispherx Biopharma, Inc.
Intercell AG
Medicago Inc.
BioDiem Ltd
Biota Holdings Limited
Mymetics Corporation
NanoViricides, Inc.
NovaBay Pharmaceuticals, Inc.
Oramed Pharmaceuticals, Inc.
Pevion Biotech Ltd
CytoGenix, Inc.
Amarillo Biosciences, Inc.
BioCryst Pharmaceuticals, Inc.
Dynavax Technologies Corporation
XOMA Ltd.
Immuron Limited
Lipoxen PLC
Green Cross Corporation
Cytos Biotechnology AG
Synairgen plc
Panacea Biotec Limited
Eurocine Vaccines AB
Antigen Express, Inc.
Functional Genetics, Inc.
Colby Pharmaceutical Company
Avanti Therapeutics
Marinomed Biotechnologie GmbH
Nutri Pharma ASA
LigoCyte Pharmaceuticals, Inc.
Evolva SA
Vironova AB
ImmunoBiology Limited
CureVac GmbH
TechnoVax, Inc.
MacroGenics, Inc.
Pulmatrix, Inc.
Okairos
Viroblock S.A.
AlphaVax, Inc.
Innate Therapeutics Limited
Vaxin, Inc.
EpiVax, Inc.
Indus Biotech Private Limited
Romark Laboratories, L.C.
Adamas Pharmaceuticals, Inc.
Theraclone Sciences, Inc.
REPLICor Inc.
Immune Targeting Systems (ITS) Ltd.
Sinovac Biotech Ltd.
Exponential Biotherapies, Inc.
NanoBio Corporation
Protein Sciences Corporation
ImmunoVaccine Technologies Inc.
VaxInnate Corporation
Etubics Corporation
Obio Pharmaceutical Holdings Limited.
Canopus BioPharma Incorporated
iBio, Inc.
PepTcell Limited
BiondVax Pharmaceuticals Ltd.
Arisyn Therapeutics Inc.
Avir Green Hills Biotechnology AG
Sirnaomics, Inc.
Vaxart, Inc.
Hawaii Biotech, Inc.
Variation Biotechnologies, Inc.
IRX Therapeutics, Inc.
NexBio, Inc.
NasVax Ltd.
ImmuneRegen BioSciences, Inc.
Trellis Bioscience, Inc.

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463824&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.